Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20141
20152
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Accenture1
Bristol-Myers Squibb1
Ciusss de L'Est de l'Île de Montréal1
Kiadis Pharma1
Kura Oncology, Inc.1
Maisonneuve-Rosemont Hospital1
Molecular Templates, Inc.1
Treadwell Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms8
Leukemia, Myeloid, Acute4
Lymphoma, Non-Hodgkin4
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia2
Multiple Myeloma2
Myelodysplastic Syndromes2
Recurrence2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.